Cetuximab-related IRs common and costly

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2010年 / 1293卷 / 1期
关键词：
Public Health; Cancer Patient; Colorectal Cancer; Medical Intervention; Cetuximab;
D O I：
10.2165/00128415-201012930-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [21] High incidence of cetuximab-related infusion reactions in head and neck cancer pts (real life data)
    Palomar, V.
    Annereau, M.
    Lezghed, N.
    Even, C.
    Mayache-Badis, L.
    Iacob, M.
    Leibu, C.
    Matias, M.
    Bravo, P.
    Ferte, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital
    Keating, Karen
    Walko, Christine
    Stephenson, Briana
    O'Neil, Bert H.
    Weiss, Jared
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (06) : 409 - 416
  • [23] Medication-related harm common and costly in elderly
    Reactions Weekly, 2018, 1704 (1) : 10 - 10
  • [24] Medication-Related Harm Common and Costly in Elderly
    不详
    PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 305 - 305
  • [25] Reply to 'Cetuximab-related skin toxicity and efficacy: do we understand the mechanisms?' by Evesque et al.
    Holch, J. W.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2020, 31 (09) : 1261 - 1262
  • [26] Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study
    Sacha I. Rothschild
    Daniel Betticher
    Reinhard Zenhäusern
    Sandro Anchisi
    Roger von Moos
    Miklos Pless
    Peter Moosmann
    Razvan A. Popescu
    Antonello Calderoni
    Marco Dressler
    Daniel Rauch
    Stefanie Pederiva
    Regina Woelky
    Claudia Papet
    Vera Bühler
    Markus Borner
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 881 - 889
  • [27] Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study
    Rothschild, Sacha I.
    Betticher, Daniel
    Zenhaeusern, Reinhard
    Anchisi, Sandro
    von Moos, Roger
    Pless, Miklos
    Moosmann, Peter
    Popescu, Razvan A.
    Calderoni, Antonello
    Dressler, Marco
    Rauch, Daniel
    Pederiva, Stefanie
    Woelky, Regina
    Papet, Claudia
    Buehler, Vera
    Borner, Markus
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 881 - 889
  • [28] A self-controlled trial of prophylactic topical application of vitamin K1 cream for cetuximab-related skin rash
    Ishikawa, H.
    Kato, T.
    Yamazaki, K.
    Taku, K.
    Tsushima, T.
    Yoshida, Y.
    Hamauchi, S.
    Yoshikawa, S.
    Yagi, H.
    Kimura, M.
    Kimura, M.
    Nakajo, M.
    Sakata, S.
    Masujima, H.
    Miyazawa, A.
    Izawa, M.
    Iwami, K.
    Yamanaka, T.
    Kiyohara, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 118 - 118
  • [29] Fewer cetuximab-related skin-toxicities in colorectal cancer patients treated with encorafenib: a Yin and Yang effect of ERK paradoxical activation
    Ciccolini, J.
    Milano, G.
    ANNALS OF ONCOLOGY, 2022, 33 (09) : 981 - 982
  • [30] HEPATITIS-A - COMMON AND COSTLY
    MARR, JS
    NEW YORK STATE JOURNAL OF MEDICINE, 1984, 84 (01) : 3 - 3
12345